Coverage All age groups Meningococcal disease
Efficacy/effectiveness Administration All age groups Meningococcal disease
Efficacy/effectiveness Safety Newborn (0-1 years) Children (2-9 years) Adolescents (10-18 years) Mumps Measles Rubella Varicella
Administration Efficacy/effectiveness Safety Newborn (0-1 years) Hepatitis B Diphtheria Pertussis Tetanus Haemophilus influenzae type B Poliomyelitis
Efficacy/effectiveness Safety Administration All age groups Haemophilus influenzae type B
Efficacy/effectiveness Safety Children (2-9 years) Adolescents (10-18 years) Meningococcal disease
Economic aspects Newborn (0-1 years) Children (2-9 years) Haemophilus influenzae type B
Efficacy/effectiveness Safety Adults (18+) Elderly (65+) Haemophilus influenzae type B
Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Adolescents (10-18 years) Adults (18+) Meningococcal disease